Trastuzumab 150 mg – 440 mg
Powder for concentrate for solution for infusion
Image
Product Description
- Hertisan contains the active substance Trastuzumab, a “monoclonal antibody” that is designed to bind selectively to an antigen called human epidermal growth factor receptor 2 (HER2). When it binds to HER2 it stops the growth of such cells and causes them to die.
- Hertisan is used in the treatment of breast cancer when:
- You have early breast cancer, with high levels of a protein called HER2.
- You have metastatic breast cancer with high levels of HER2, in combination with the chemotherapy medicine.
- Hertisan is used in the treatment of gastric cancer when:
- You have metastatic gastric cancer with high levels of HER2, in combination with the other cancer medicines.